Frequency and Outcomes of Periprocedural MI in Patients With Chronic Coronary Syndromes Undergoing PCI.

Ueki, Yasushi; Otsuka, Tatsuhiko; Bär, Sarah; Koskinas, Konstantinos C.; Heg, Dik; Häner, Jonas; Siontis, George C.M.; Praz, Fabien; Hunziker, Lukas; Lanz, Jonas; Stortecky, Stefan; Pilgrim, Thomas; Losdat, Sylvain; Windecker, Stephan; Räber, Lorenz (2022). Frequency and Outcomes of Periprocedural MI in Patients With Chronic Coronary Syndromes Undergoing PCI. Journal of the American College of Cardiology, 79(6), pp. 513-526. Elsevier 10.1016/j.jacc.2021.11.047

[img] Text
Ueki_JAmCollCardiol_2022.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (1MB) | Request a copy

BACKGROUND

Definitions of periprocedural myocardial infarction (MI) differ with respect to biomarker threshold as well as ancillary criteria for myocardial ischemia and are limited in terms of validation.

OBJECTIVES

This study evaluated the frequency and impact of periprocedural MI by using various MI definitions among patients with chronic coronary syndrome (CCS) undergoing percutaneous coronary intervention (PCI).

METHODS

Between 2010 and 2018, periprocedural MIs were assessed according to the third and fourth Universal Definition of Myocardial Infarction (UDMI), Academic Research Consortium-2 (ARC-2), and Society for Cardiovascular Angiography and Interventions (SCAI) criteria based on high-sensitivity troponin in patients with CCS undergoing PCI enrolled into the Bern PCI registry. The primary endpoint was cardiac death at 1 year.

RESULTS

Among 4,404 patients with CCS, periprocedural MI defined by the third UDMI, fourth UDMI, ARC-2, and SCAI were observed in 18.0%, 14.9%, 2.0%, and 2.0% of patients, respectively. Among patients with periprocedural MI defined by the third UDMI, fourth UDMI, ARC-2, and SCAI, cardiac mortality at 1 year was 2.9%, 3.0%, 5.8%, and 10.0%. The ARC-2 (HR: 3.90; 95% CI: 1.54-9.93) and SCAI (HR: 7.66; 95% CI: 3.64-16.11) were more relevant compared with the third UDMI (HR: 1.76; 95% CI: 1.04-3.00) and fourth UDMI (HR: 1.93; 95% CI: 1.11-3.37) for cardiac death at 1 year.

CONCLUSIONS

Among patients with CCS undergoing PCI, periprocedural MI defined according to the ARC-2 and SCAI criteria was 7 to 9 times less frequent compared with the third and fourth UDMI. Periprocedural MI defined by using the ARC-2 and SCAI were more prognostic for cardiac death at 1 year compared with the third and fourth UDMI. (CARDIOBASE Bern PCI Registry; NCT02241291).

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology
04 Faculty of Medicine > Pre-clinic Human Medicine > Department of Clinical Research (DCR)

UniBE Contributor:

Ueki, Yasushi, Otsuka, Tatsuhiko, Bär, Sarah, Koskinas, Konstantinos, Heg, Dierik Hans, Häner, Jonas, Siontis, Georgios, Praz, Fabien Daniel, Hunziker Munsch, Lukas Christoph, Lanz, Jonas, Stortecky, Stefan, Pilgrim, Thomas, Losdat, Sylvain Pierre, Windecker, Stephan, Räber, Lorenz

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0735-1097

Publisher:

Elsevier

Language:

English

Submitter:

Andrea Flükiger-Flückiger

Date Deposited:

17 Feb 2022 16:31

Last Modified:

20 Feb 2024 14:16

Publisher DOI:

10.1016/j.jacc.2021.11.047

PubMed ID:

35144742

Uncontrolled Keywords:

chronic coronary syndrome coronary artery disease myocardial infarction percutaneous coronary intervention

BORIS DOI:

10.48350/165678

URI:

https://boris.unibe.ch/id/eprint/165678

Actions (login required)

Edit item Edit item
Provide Feedback